Clinical trial
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in…
NCT00409643 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00409643 |
|---|---|
| Title | Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients |
| Official title | A Randomized, Double-blind, Multicenter, Multifactorial, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Valsartan (160 mg and 320 mg) and Amlodipine (10 mg) Combined and Alone in Hypertensive Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan+amlodipine combination, valsartan, amlodipine |
| Enrollment | 1,259 |
| Start date | Jan 1, 2004 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Dec 11, 2006 |
| Last update posted | Nov 8, 2011 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: